Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Dou

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Cancer Research|April 1, 1993
Cyclin E and cyclin A as candidates for the restriction point proteinQ P Dou, A H Levin, S Zhao, et al.
Nanoscale|November 14, 2015
Tailoring the transmission lineshape spectrum of zigzag graphene nanoribbon based heterojunctions via controlling their width and edge protrusionsK P Dou, X X Fu, Abir De Sarkar, et al.
Oncogene|June 23, 2001
Sequential two-step cleavage of the retinoblastoma protein by caspase-3/-7 during etoposide-induced apoptosisC L Fattman, S M Delach, Q P Dou, et al.
International Journal of Molecular Medicine|October 13, 2000
Regulation of tumor cell apoptotic sensitivity during the cell cycle (Review)D M Smith, G Gao, X Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1990
Transformed and nontransformed cells differ in stability and cell cycle regulation of a binding activity to the murine thymidine kinase promoterD W Bradley, Q P Dou, J L Fridovich-Keil, et al.
International Journal of Molecular Medicine|December 16, 1998
Bcl-2- and CrmA-inhibitable dephosphorylation and cleavage of retinoblastoma protein during etoposide-induced apoptosisB An, D E Johnson, J R Jin, et al.
Current Protein & Peptide Science|June 10, 2008
Natural compounds with proteasome inhibitory activity for cancer prevention and treatmentH Yang, K R Landis-Piwowar, D Chen, et al.
Current Medicinal Chemistry|July 1, 2010
Turning tumor-promoting copper into an anti-cancer weapon via high-throughput chemistryF Wang, P Jiao, M Qi, et al.
Zhonghua Yi Xue Za Zhi|April 9, 2023
[Effects of three medical nutrition therapies for weight loss on metabolic parameters and androgen level in overweight/obese patients with polycystic ovary syndrome]P Dou, T T Zhang, Y Xu, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|February 1, 1991
Growth-responsive expression from the murine thymidine kinase promoter: genetic analysis of DNA sequencesJ L Fridovich-Keil, J M Gudas, Q P Dou, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Cancer Research|April 1, 1993
Cyclin E and cyclin A as candidates for the restriction point proteinQ P Dou, A H Levin, S Zhao, et al.
Nanoscale|November 14, 2015
Tailoring the transmission lineshape spectrum of zigzag graphene nanoribbon based heterojunctions via controlling their width and edge protrusionsK P Dou, X X Fu, Abir De Sarkar, et al.
Oncogene|June 23, 2001
Sequential two-step cleavage of the retinoblastoma protein by caspase-3/-7 during etoposide-induced apoptosisC L Fattman, S M Delach, Q P Dou, et al.
International Journal of Molecular Medicine|October 13, 2000
Regulation of tumor cell apoptotic sensitivity during the cell cycle (Review)D M Smith, G Gao, X Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1990
Transformed and nontransformed cells differ in stability and cell cycle regulation of a binding activity to the murine thymidine kinase promoterD W Bradley, Q P Dou, J L Fridovich-Keil, et al.
International Journal of Molecular Medicine|December 16, 1998
Bcl-2- and CrmA-inhibitable dephosphorylation and cleavage of retinoblastoma protein during etoposide-induced apoptosisB An, D E Johnson, J R Jin, et al.
Current Protein & Peptide Science|June 10, 2008
Natural compounds with proteasome inhibitory activity for cancer prevention and treatmentH Yang, K R Landis-Piwowar, D Chen, et al.
Current Medicinal Chemistry|July 1, 2010
Turning tumor-promoting copper into an anti-cancer weapon via high-throughput chemistryF Wang, P Jiao, M Qi, et al.
Zhonghua Yi Xue Za Zhi|April 9, 2023
[Effects of three medical nutrition therapies for weight loss on metabolic parameters and androgen level in overweight/obese patients with polycystic ovary syndrome]P Dou, T T Zhang, Y Xu, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|February 1, 1991
Growth-responsive expression from the murine thymidine kinase promoter: genetic analysis of DNA sequencesJ L Fridovich-Keil, J M Gudas, Q P Dou, et al.
Pageof 7